Infectious diseases don't wait.
Neither do we

We protect children's futures from pregnancy through
adolescence with equitable science

Get to know us


Penta is an international independent scientific network dedicated to maternal and child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in 124 clinical sites and 26 cohorts across 27 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Meet the 2026 Penta Brighter Future Award (BFA) winners!

This prestigious biennial award recognises visionary leaders dedicated to dismantling health inequities in maternal and child infectious diseases, specifically targeting HIV, tuberculosis (TB), vaccine access and the fortification of fragile health systems.

Penta Strategy 2025-2029: building on progress, driving strategic impact

Building on the results of our previous strategy, Penta’s 2025-2029 Strategic Plan focuses on accelerating scientific impact through high-quality research and strategic partnerships, especially in regions with the greatest need.

Penta advocates for equitable access to healthcare across all activities and strives to engage with affected and at-risk communities to maximise impact.

 

Current Penta studies around the World



Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Previous

Latest News

Next

Making older antibiotics work safely for children with sepsis. An interview with the SNIP-AFRICA team

09 Sep, 2026

Around the world, more bacterial infections are growing resistant to standard antibiotics, making them harder to treat. Antimicrobial resistance is especially dangerous for critically ill newborns, infants and young children,
Read More

Children must not be left behind in Bundibugyo virus disease research, Penta experts warn

01 Sep, 2026

Penta ID Network members and Scientific Steering Committee chairs Ali Judd and Pablo Rojo have co-authored a commentary in The Lancet Child & Adolescent Health calling for urgent action to…
Read More

From Hospital to Home: Why Going Home Isn’t the End – Follow-up Care as a Life-Saver

01 Sep, 2026

For most families, leaving the hospital is a moment of relief. It signals recovery, hope, and a return to normal life. But for children living with HIV who have been…
Read More

Penta reaffirms its commitment to evidence-based childhood vaccination

31 Aug, 2026

In recent years, we have seen a resurgence of vaccine-preventable diseases, reversing progress that could have been sustained through effective immunisation programmes. Penta strongly supports childhood vaccination as one of…
Read More

Penta Young Reporters shine at AIDS 2026 and the International Workshop on Pediatrics & HIV

28 Aug, 2026

This year, the Penta Young Reporters attended the 18th International Workshop on Pediatrics & HIV and the AIDS 2026 Conference in Rio de Janeiro, Brazil. It was fantastic to see…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people